Log in
Enquire now
‌

US Patent 11832876 Treating upper airway nerve tissue

Patent 11832876 was granted and assigned to Aerin Medical on December, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Aerin Medical
Aerin Medical
0
Current Assignee
Aerin Medical
Aerin Medical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118328760
Patent Inventor Names
Andrew Frazier0
Scott J. Wolf0
Date of Patent
December 5, 2023
0
Patent Application Number
176545310
Date Filed
March 11, 2022
0
Patent Citations
‌
US Patent 7322993 Stiffening pharyngeal wall treatment
0
‌
US Patent 7361168 Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
0
‌
US Patent 7416550 Method and apparatus for the control and monitoring of shape change in tissue
0
‌
US Patent 7442191 Systems and methods for electrosurgical treatment of turbinates
0
‌
US Patent 7655243 Methods and systems for toxin delivery to the nasal cavity
0
‌
US Patent 7678069 System for electrosurgical tissue treatment in the presence of electrically conductive fluid
0
‌
US Patent 7780730 Nasal implant introduced through a non-surgical injection technique
0
‌
US Patent 7824394 Method and apparatus for dermatological treatment and tissue reshaping
0
...
Patent Primary Examiner
‌
Paula J Stice
0
CPC Code
‌
A61B 2018/00922
0
‌
A61B 2018/00214
0
‌
A61B 2018/00797
0
‌
A61B 2018/1497
0
‌
A61F 5/08
0
‌
A61M 25/10
0
‌
A61N 1/0546
0
‌
A61B 18/1485
0
...
Patent abstract

Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11832876 Treating upper airway nerve tissue

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.